Thus, a higher expression of CA125, CA15-3, CEA, CYFRA21-1, SCC, and TAG72-3 in the serum samples of patients is considered an early detection biomarker of NSCLC. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.